Brief: Allena Pharmaceuticals Posts Quarterly Loss Per Share Of 0.24

Allena Pharmaceuticals

10/08/2021 23:07

Aug 10 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND RECENT CORPORATE PROGRESS
    * ALLENA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.24
    * ALLENA PHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS
BALANCE
AS OF JUNE 30, 2021 WAS $26.7 MILLION
    * ALLENA PHARMACEUTICALS INC - UPDATED PLAN AND TIMING FOR
FIRST
INTERIM ANALYSIS OF PHASE 3 URIROX-2 CLINICAL TRIAL OF
RELOXALIASE
    * ALLENA PHARMACEUTICALS - NOW SEES TO CONDUCT FIRST INTERIM
ANALYSIS OF URIROX-2 PHASE 3 TRIAL DURING Q1 2022

Source text for Eikon:  ID:nGNXb4kfSj 
Further company coverage:  ALNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))